A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma
Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/00002371-200407000-00001
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2004
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)